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TO THE EDITOR
Corticotropin-releasing hormone (CRH),
a 41-amino-acid peptide, is a main
regulator of the systemic response that
suppresses immune response on a central
level (Chrousos and Gold, 1992). In the
peripheral sites, including the epidermis,
CRH acts as potent proinflammatory
agent (Karalis et al., 1991; Theoharides
et al., 2004; Slominski et al., 2006a, b). In
normal keratinocytes, CRH activates the
master regulator of inflammation NF-kB
(Zbytek et al., 2004) and stimulates the
expression of ICAM-1 and HLA-DR
(Quevedo et al., 2001).
Epidermal keratinocytes take part in
inflammatory responses initiated by
various stressors (Barker et al., 1991).
Induction of production of inflam-
matory cytokines in normal keratino-
cytes by bacteria occurs via toll-like
receptor (TLR)-2 and TLR-4 (Nagy
et al., 2005). Therefore, there is a
need for the functional study of the
link between bacteria, CRH, and
inflammatory cytokines in human
keratinocytes.
Normal human epidermal adult
keratinocytes (purchased from Cascade
Biologics, Portland, OR) were incu-
bated with CRH, lipopolysaccharide
(LPS; TLR-4 agonist, Sigma, St Louis,
MO) or PAM3CSK4 (TLR-2 agonist,
EMC microcollections, Tuebingen, Ger-
many) in EpiLife medium with epilife
defined growth supplement (EDGS)
supplement and antibiotics (Cascade
Biologics, Portland, OR). Thereafter,
supernatants were collected and RNA
extracted from the cells. Supernatants
were concentrated on C18 SEP-COL-
UMNS (Peninsula Laboratories, San
Carlos, CA) and CRH was measured
with ELISA (Phoenix Pharmaceuticals,
Belmont, CA). CRH mRNA and
18SrRNA amounts were quantitated
with real-time PCR using Taqman
reagents (Applied Biosystems, Foster
City, CA) as described previously
(Zbytek et al., 2006). Cytokine mRNAs
were quantitated by the following
ABI reagents: Hs00174128_m1,
Hs00174097_m1, Hs00174131_m1,
and Hs00174086_m1. Small interfering
RNA (siRNA) (CRH-R1-specific and
scrambled, Ambion, Austin, TX) was
transfected into the cells as described
(Slominski et al., 2005). The medical
ethical committee of University of
Tennessee approved all described
studies.
LPS (TLR-4 agonist) but not
PAM3CSK4 (TLR-2 agonist) stimulated
the expression of CRH mRNA (Figure
1a and b). The effect was most signi-
ficant at 1 hour at 1,000 ng/ml being
5.4-fold higher than in control. LPS also
stimulated the release of the peptide to
the supernatant (Figure 1c). At 24 hours,
LPS at 1,000 ng/ml stimulated it 14.9-
fold. As regards the physiological signi-
ficance of effect of LPS on CRH
production, it was previously shown
that cells that initiate stress response in
the organism (hypothalamic neurons)
produce CRH upon LPS stimulation
(Chrousos and Gold, 1992; Wei et al.,
2002). We provide data showing that
similar phenomenon takes place in the
epidermal keratinocytes.
Having determined that LPS has
stimulated production and release of
CRH, we decided to test the effects of
CRH on the production of selected
cytokines that play a role in the regula-
tion of the mode of immune response
(T-helper cell 1 versus T-helper cell 2).
The cytokines tested were tumor ne-
crosis factor-a (TNF-a), IL-1b, IL-6, and
IL-10. CRH stimulated the expression of
IL-1b, IL-6, and TNF-a mRNAs, but did
not stimulate the expression of IL-10
mRNA (whose amount was below
the limit of detection) (Figure 2a–c).
The most significant stimulatory effects,
reached at 1 hour, were 12.9-fold
(TNF-a), 8.5-fold (IL-1b), and 7.3-fold
(IL-6). Hitherto, CRH stimulated the
production of inflammatory and T-help-
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Figure 1. LPS stimulates CRH in normal human
adult epidermal keratinocytes. Cells were
incubated (a) with LPS (0–1,000 ng/ml) for 1 hour
and (b) with LPS (1,000 ng/ml) for 1–24 hours.
Cells were lysed, total RNA extracted, and
real-time PCRs (n¼ 3) performed for CRH.
(c) Cells were incubated with LPS (0–1,000 ng/ml).
After 24 hours, the supernatants were collected,
concentrated on C18 SEP-COLUMNS, and
CRH determined by ELISA (n¼4). Data are
presented as mean7SEM. *Po0.05 between
untreated and LPS-treated cells.
Abbreviations: CRH, corticotropin-releasing hormone; LPS, lipopolysaccharide; siRNA, small interfering
RNA; TLR, toll-like receptor; TNF-a, tumor necrosis factor-a
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cell 2- (IL-10) upregulating cytokines.
This effect of CRH is consistent with its
previously reported proinflammatory
(Theoharides et al., 2004) and selective
T-helper cell 1-enhancing effects
(Benou et al., 2005).
To further document a role of CRH-
CRH-R1 signaling in the response of
keratinocytes to bacteria, we trans-
fected keratinocytes with CRH-R1 siR-
NA or scrambled (control) siRNA. After
48 hours, the cells were stimulated with
LPS, and then, after 1 hour, levels of
cytokine mRNA measured. CRH-R1
siRNA-transfected cells responded
with diminished production of TNF-a
(by 80%), IL-1b (by 84%), and IL-6
(by 84%) as compared to cells trans-
fected with control siRNA (insets in
Figure 2a–c). This indicates that en-
hanced production of inflammatory
cytokines is dependent on CRH-R1
expression.
Locally released CRH may play a
role in inflammatory and immune-
mediated skin diseases such as psor-
iasis, alopecia areata or acne (O’Kane
et al., 2006). We have previously
reported that CRH stimulates epidermal
keratinocyte differentiation (Zbytek and
Slominski, 2005), which exclusively
express CRH-R1 (Slominski et al.,
2006b). Zouboulis et al. (2002) re-
ported that CRH induces synthesis of
sebaceous lipids. UV was shown to
upregulate CRH release (Zbytek et al.,
2006). This report shows that CRH may
serve as a local autocrine mediator that
amplifies inflammatory responses to
bacterial antigens and hence may be
an important target for the treatment of
several skin conditions.
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Figure 2. CRH and CRH-R1 participate in the
LPS-mediated stimulation of inflammatory
cytokine mRNA expression in normal human
adult epidermal keratinocytes. Main panels:
Keratinocytes were incubated with or without
100 nM CRH for 1–24 hours. Insets: Keratinocytes
were transfected with either scrambled (control) or
CRH-R1-specific siRNA. Forty-eight hours after
transfection, media were changed and cells
stimulated with LPS (1,000 ng/ml) for 1 hour.
After incubations, cells were lysed, total RNA
extracted, and real-time PCRs performed for
(a) TNF-a, (b) IL-1b, and (c) IL-6. Data are
presented as mean7SEM (n¼ 3). *Po0.05,
**Po0.005 between untreated and CRH-treated
cells or cells transfected with scrambled or
CRH-R1 siRNA (insets).
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